Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SBNO1 antisense RNA 1 (SBNO1-AS1) is presumed to be a long non-coding RNA (lncRNA) transcribed from the strand antisense to the SBNO1 gene (Strawberry Notch Homolog 1). Antisense RNAs including lncRNAs are typically involved in regulating gene expression, commonly affecting the transcription or translation of the gene from which they are derived or neighboring genes[2]. There is no established role for SBNO1-AS1 in human disease, drug response, or as a therapeutic target. The general biological context for antisense lncRNAs suggests possible functions in chromatin remodeling, transcriptional interference, or RNA stability, but no experimental data are available regarding the precise functional or pathophysiological relevance for SBNO1-AS1 specifically[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SBNO1 antisense RNA 1 (SBNO1-AS1).